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Congenital anomalies of the kidney and urinary tract (CAKUTs) are common disorders of human develop-
ment affecting the renal parechyma, renal pelvis, ureter, bladder and urethra; they show evidence of
shared genetic aetiology, although the molecular basis of this remains unknown in the majority of cases.
Breakpoint mapping of a de novo, apparently balanced, reciprocal translocation associated with bilateral
renal agenesis has implicated the gene encoding the nuclear steroid hormone receptor ESRRG as a candi-
date gene for CAKUT. Here we show that the Esrrg protein is detected throughout early ureteric ducts as
cytoplasmic/sub-membranous staining; with nuclear localization seen in developing nephrons. In 14.5–
16.5 dpc (days post-conception) mouse embryos, Esrrg localizes to the subset of ductal tissue within the
kidney, liver and lung. The renal ductal expression becomes localized to renal papilla by 18.5 dpc.
Perturbation of function was performed in embryonic mouse kidney culture using pooled siRNA to induce
knock-down and a specific small-molecule agonist to induce aberrant activation of Esrrg. Both resulted in
severe abnormality of early branching events of the ureteric duct. Mouse embryos with a targeted inactivation
of Esrrg on both alleles (Esrrg2/2) showed agenesis of the renal papilla but normal development of the cortex
and remaining medulla. Taken together, these results suggest that Esrrg is required for early branching
events of the ureteric duct that occur prior to the onset of nephrogenesis. These findings confirm ESRRG
as a strong candidate gene for CAKUT.
INTRODUCTION
Formation of the primary nephric duct as symmetric bilateral
cords of epithelial cells (1) at 22 gestational days in human
embryos is the first evidence of kidney development. A transi-
ent embryonic kidney, the mesonephros, then forms along the
long axis of the nephric duct (2) with the definitive kidney or
metanephros forming via an outgrowth of the distal nephric
duct, the ureteric bud, which then undergoes extensive branch-
ing and induces the surrounding mesoderm to form glomeruli
and nephrons (3,4). The first 6–10 generations of ureteric
branching events will form the pelvis and calyces and are
not associated with nephrogenesis (5). The molecules deter-
mining the position of the boundaries between ureter and
renal pelvis or between renal papilla and collecting duct fate
have not yet been identified.
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Congenital anomaly of the kidney and urinary tract
(CAKUT) is a term used to describe a common and medically
important group of developmental disorders of the kidney,
renal pelvis, ureter, bladder and urethra. Malformations of
these anatomically distinct structures show evidence of
shared aetiology on the basis of coexistence of different mal-
formations in individual cases, family studies and animal
models. The most severe forms of CAKUT, bilateral renal
agenesis/hypoplasia/dysplasia (BRAHD), are malformations
of the renal parenchyma that are usually lethal. We recently
reported breakpoint mapping of a de novo, apparently
balanced reciprocal translocation, t(1;2)(q41;p25.3) (6),
associated with non-syndromal bilateral renal agenesis. At
the 1q41 breakpoint, aberrant cis-regulation of ESRRG was
identified as a candidate mechanism for BRAHD in this case
(7) on the basis of proximity to the breakpoint and strong
expression in the developing kidney assess by whole-mount
in situ hybridization using an antisense riboprobe. ESRRG
encodes an orphan nuclear steroid hormone receptor pre-
viously known as estrogen-related receptor gamma. No
endogenous ligand is known for ESRRG and ligand-binding
may not be essential for at least some aspects of transcriptional
activity (8). However, specific small molecule agonists (9–12)
and antagonists (8) of ESRRG have been identified.
Here we functionally assess ESRRG as a candidate gene for
CAKUT. We show that Esrrg expression is limited to proximal
(i.e. closest to the ureter) ductal tissue, which is derived from
the early generations of branching of the ureteric bud. Both
activation and inactivation of this nuclear steroid hormone
receptor result in severe abnormality of early branching
events in cultured kidneys. Analysis of mouse embryos with
a targeted inactivation of Esrrg on both alleles (Esrrg2/2)
showed an unusual and previously unsuspected anomaly of
renal papillary agenesis.
RESULTS
Expression of Esrrg during mouse embryogenesis
Immunohistochemical analysis of Esrrg in wild-type embryos
showed strong and persistent staining in the primitive ventri-
cle, atrium and truncus arteriosus (TA) of the developing
heart from 9.5 dpc (Fig. 1). Strong expression is also seen in
a subset of the head mesenchyme from 9.5 to 12.5 dpc.
Faint staining in the dorsal aspect of the otic vesicle is detect-
able at 9.5 dpc. From 10.5 dpc, strong staining is seen in the
branching bronchial tree of the developing lung. By
11.5 dpc, strong staining is also apparent in the urogenital
Figure 1. Esrrg immunohistochemistry on sectioned mouse embryos. Photomicrographs of Esrrg immunohistochemical staining of saggital sections of mouse
embryos counterstained with eosin (pink) and signal detected with NBT/BCIP (blue). (A) 9.5 dpc embryo showing strong staining in the primitive ventricle,
atrium and TA. There is also expression seen in the head mesenchyme (mes) and faint staining in the dorsal aspect of the otic vesicle. (B) 10.5 dpc embryo
showing continued strong staining in the developing heart. There is also a prominent signal in the developing lung bud and expression in the head mesenchyme.
(C) 11.5 dpc embryo showing strong expression in the heart, lung and condensing mesenchyme in the head. New regions of strong staining are now apparent in
the urogenital sinus and the duodenum. Faint expression can be seen in the ducts within the liver. (D) 12.5 dpc embryo showing a very similar expression pattern
to 11.5 dpc.
918 Human Molecular Genetics, 2011, Vol. 20, No. 5
sinus and the duodenum with faint expression detectable in the
ducts within the liver.
Expression of Esrrg during in vivo and in vitro kidney
development
In dissected wild-type embryonic kidneys, expression is
observed in the peripheral metanephric mesenchyme towards
the outer edge of the developing kidney at 12.5 dpc. In later
stages, expression is seen in the capsule, the adrenal gland
and a subset of the ductal tissue within the kidney parench-
yma, which forms by branching of the ureteric bud. By
15.5 dpc, the ductal staining appears to be localized to
the developing collecting ducts (Fig. 2). By 18.5 dpc, the
expression is localized to the collecting ducts in the develop-
ing renal papilla and this persists in the neonate kidney. From
14.5 dpc, the nephrons are negative for Esrrg staining. There is
a clear staining of Esrrg in the ureteric smooth muscle at P0
(Fig. 2). No expression could be seen in the adult mouse
kidney sections examined (data not shown).
In vitro culture of wild-type embryonic kidneys was used
for more detailed analysis of the expression pattern of Esrrg
in the ureteric bud. In this system, Esrrg staining was found
to be entirely ductal (Fig. 3A–F). The strongest Esrrg staining
partially overlapped with Pax8 in the peripheral ductal tissue
(Fig. 3A and C). In most cells, expression of Esrrg and Wt1,
a marker for condensing mesenchyme and developing glomer-
uli, appears to be non-overlapping (Fig. 3B and D). A sugges-
tion of a site-specific change in subcellular distribution of
Esrrg was observed; in the proximal ducts, there was apparent
staining in the cytoplasmic/sub-membranous compartment of
cells (Fig. 3F); however, in the developing nephron, the stain-
ing was nuclear (Fig. 3E).
Effect of siRNA knock-down of Ush2a and Esrrg in
cultured embryonic kidneys
Pools of siRNAs targeted against either Esrrg or Ush2a were
transfected into explanted mouse embryonic kidneys. Ush2a
was chosen as a comparator because this is the closest neigh-
bouring gene to Esrrg, and USH2A is directly disrupted by the
1q41 translocation breakpoint associated with bilateral renal
agenesis (6). However, USH2A is not a good candidate for
this phenotype as homozygous loss-of-function mutations in
humans and mice result in hearing loss and retinal degener-
ation with no renal phenotype (7). Culture of the explants fol-
lowing siRNA transfection revealed a striking growth arrest in
the Esrrg targeted kidneys that were not seen in Ush2a or the
mock transfections (Fig. 4A). A statistically significant
reduction in the number of nephrons and the number of bud
tips was observed in the Esrrg targeted tissues (Fig. 4B).
Figure 2. Esrrg immunohistochemistry on sectioned embryonic mouse kidney. Photomicrographs of kidney sections counterstained with eosin (pink) and Esrrg
is detected with NBT/BCIP (blue). 12.5 dpc staining in early-stage kidneys can only be seen in the peripheral uncondensed metanephric mesenchyme or stroma.
14.5, 15.5, 16.5 dpc: each kidney shows regionally restricted signal in specific ductal epithelia and in the peripheral mesenchyme. 18.5 dpc and P0 (first postnatal
day): signal becomes restricted to the renal papilla and the developing ureter.
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Effect of a specific Esrrg agonist on cultured embryonic
kidneys
Specific agonists for Esrrg have been developed (13). We used
one of these, GSK4716, to examine the effect of constitutional
activation of Esrrg in cultured embryonic kidneys. Compared
with unexposed control embryos, there was a dose-dependent
developmental anomaly evident from 2 mM concentration
GSK4716. At 10 mM concentration, all the exposed kidneys
showed a severe developmental anomaly characterized by
reduced size and abnormality in ductal morphogenesis (Fig. 5).
Kidney development in Esrrg-deficient animals
We first examined 17 dpc embryonic kidneys dissected from
wild-type, and Esrrg+/2 and Esrrg2/2 littermates were
imaged by optical projection tomography (OPT). Digital
reconstructions of each kidney were visualized in 3D and
midline digital sections chosen for each kidney. This showed
a clear morpholgical difference between the Esrrg2/2
kidneys and those from heterozygous or wild-type embryos
(Fig. 6). The most striking difference was the flattening of
the region of the papilla leading to an increase in luminal
volume in 6/6 the mutant kidneys. A similar change was
seen in only 1/8 of the wild-type embryos and 1/6 of the het-
erozygous embryos. Quantitation of the luminal volume of
whole kidneys and the ratio of lumen to renal parenchyma
showed the knock-out (KO) embryos to be clearly different
from their heterozygous and wild-type littermates.
Histopathological examination using sections from the same
Esrrg2/2 embryonic kidneys, as shown in Figure 6, showed
marked distortion of normal medullary architecture (Fig. 7D
Figure 3. Immunohistochemistry of cultured embryonic mouse kidney. Photomicrographs of embryonic mouse kidneys collected at 11.5 dpc and cultured for 3
days. (A and B) Representative cultured wild-type kidney stained by co-immunofluorescence with antibodies for Esrrg (green, A and B), Pax8 (red, A) and Wt1
(red, B). Esrrg staining is ductal with stronger staining apparent at the periphery. Esrrg partially overlaps with Pax8 in the peripheral ductal tissue (C), but was
generally distinct from that of Wt1, which marks the developing glomeruli (D). A possible site-specific phenomenon was observed in the subcellular distribution
of Esrrg; in the central ducts, the staining was diffuse suggesting cytoplasmic or sub-membranous distribution (E), but the staining was clearly nuclear (F) in the
developing nephron.
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and F) compared with the wild-type (Fig. 7A–C) in the pres-
ence of nearly normal cortical architecture and nephrogenesis
(Fig. 7E). The medulla, instead of forming a normal blunt cone
projecting into the pelvis, forms a concave disc beneath the
cortex over a widely dilated pelvis. There was no indication
of hydronephrosis, as the ureter is not dilated (Fig. 7D).
However, the Esrrg2/2 cortex shows the same maturational
gradient as the wild-type from condensation through tubular
maturation (Fig. 7E). Glomerular maturation appeared slightly
retarded. The medulla, although architecturally abnormal,
contains radiating collecting ducts, primitive loops of Henle
and palisades of interstitial cells (Fig. 7F). Both the quantitat-
ive and histological analyses are consistent with a diagnosis of
specific papillary agenesis.
In order to assess the genesis of these morphological
anomalies, kidneys were examined at an earlier developmental
stage (14.5 dpc). No difference could be detected between any
of the three genotypes on histological examination or using
immunohistochemical assays to assess proliferation or apopto-
sis (Fig. 8).
Figure 4. siRNA knock-down in cultured embryonic mouse kidney. siRNA experiments. (A) Photomicrographs showing three representative cultured kidneys
stained with laminin (red) and calbindin (green) following either mock transfection (lipofectamine) or transfections with pools of siRNA molecules targeted to
Ush2a or Esrrg. No difference is apparent between lipofectamine- and Ush2a-treated kidneys, but kidneys exposed to Esrrg siRNA are smaller and have fewer
ductal branch points. (B) Graph showing the quantitative differences in numbers of bud tips (blue) and nephrons (purple). The error bars indicate the 95% con-
fidence intervals and the numbers of kidneys used to generate the data are given above the relevant graph bars.
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DISCUSSION
Breakpoint mapping of de novo, apparently balanced recipro-
cal translocation, has proven to be an efficient method of iden-
tifying the genetic basis of human malformations (14,15). We
have recently mapped the breakpoints of a t(1;2)(q41;p25.3)
associated with isolated bilateral renal agenesis. This analysis
suggested that misregulation of the ESRRG gene that mapped
close to the chromosome 1q41 breakpoint was a plausible can-
didate developmental genetic mechanism for the kidney mal-
formation in this case on the basis of striking site-specific
expression in the 14.5 dpc embryonic mouse kidney.
Here we have sought to clarify the non-redundant role of
ESRRG in kidney development. Immunohistochemical analy-
sis shows that Esrrg is widely expressed in a site-specific
manner during mouse embryogenesis. The earliest expression
is seen in the developing heart from 9.5 dpc. Expression is also
seen in a sub-population of head mesenchyme. From 11.5 dpc,
it is striking that several tubular/ductal structures strongly
express Esrrg; the Wolfian duct and urogenital sinus, the
lung bud and the duodenum. Weaker expression is seen in
hepatic ducts. During the development of the metanephic
kidney, expression is first seen in the peripheral stroma sur-
rounding the invading ureteric bud. The subsequent expression
is ductal and is strikingly regionally restricted. It is intriguing
that the subcellular distribution of Esrrg is clearly nuclear in
the developing nephrons of the cultured embryonic kidney
explants with a suggestion that there is lower level expression
in the proximal ductal tissue that is cytoplasmic or submem-
branous. It will be interesting to identify the molecular basis
of this nuclear translocation and any resulting transcriptional
response. However, on the basis of the phenotype in
Esrrg2/2 mice, it is very unlikely that this gene product has
a non-redundant role in nephron development.
We also provide in vitro and in vivo evidence for a non-
redundant role for Esrrg in kidney development. The siRNA
transfections of explant mouse embryo kidney cultures
yielded a severe phenotype consistent with an interruption of
ductal branching. This phenotype has been confirmed as
specific by using a second, independent pool of three siRNA
targeting different regions of Esrrg (data not shown). No
effect is seen on kidney development using siRNA targeted
against the neighbouring gene in both the mouse and human
genome, Ush2a/USH2A. We show a remarkably similar, dose-
dependent phenotype associated with pharmacological acti-
vation of ESRRG using a specific agonist, GSK4716. It is,
however, important to acknowledge that the specificity of
small molecule agonists may be tissue and/or species specific,
and these results must be interpreted with some caution.
More convincing evidence for a non-redundant role during
kidney development comes from the targeted KO of Esrrg in
the mouse (16). The targeted mutation removes most of the
DNA binding domain of Esrrg coded for in exon 2 and replaces
this with an in-frame, promotorless beta-galactosidase cassette.
Esrrg2/2 mice die perinatally and have hyperlactataemia, a car-
diomyopathy and a cardiac conduction defect. Transcriptome
analysis of the cardiac tissue from affected homozygotes
revealed abnormalities in key mitochondrial genes. There was
no suspicion of a renal phenotype in these mice. In view of the
results obtained from the siRNA experiments, we decided to
investigate the kidneys of the Esrrg2/2 by detailed histology
andmorphometry. This showed a very site-specific developmen-
tal anomaly of the renal papilla in the KO mice compared with
heterozygous and wild-type littermates. At the level of OPT
analysis, the kidney phenotype was suggestive of fetal hydrone-
phrosis. Recent animal model work has highlighted abnormal-
ities in ureteric peristalsis as an important cause of fetal
hydronephrosis (17,18), and Esrrg staining is evident in themus-
culature of the ureter (Fig. 2). However, on histological analysis,
there was no evidence of increased pressure—in particular, there
was no evidence of dilation of the collecting duct. We thus con-
sider it likely that theEsrrgKOmice have agenesis of the papilla
as a primarymalformation rather than a dysplastic effect second-
ary to increased hydrostatic pressure within the ductal system.
Figure 5. The effect of the Esrrg agonist GSK4716 on cultured embryonic mouse kidney. Effect of exposure to GSK4716. Photomicrographs showing three
representative cultured kidneys stained with laminin (red) and calbindin (green) exposed to either none (control) or increasing concentrations (1–10 mM) of
the Esrrg agonist GSK4716. At 10 mM concentration, there is a severe developmental anomaly in the exposed embryos with an apparent dose-dependent
effect at lower concentrations.
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The primary function of the renal papilla is thought to be in final
maximal concentration of urine (19,20). Currently, it would not
be possible to test theEsrrg2/2mice for defects in urine concen-
tration in view of the earlymortality, but thismay be possible in a
conditional KO model.
The onset of the morphological change in vivo can be timed
between 14.5 and 17 dpc. At 14.5 dpc, the KO kidneys are his-
tologically indistinguishable from the wild-type. There was no
obvious defect in either proliferation or apoptosis seen in the
14.5 dpc KO kidneys. The renal papilla cannot be visualized
at this stage and the 14.5 dpc kidneys are too small for accu-
rate dissection for OPT analysis of the ductal branch patterns.
Thus, the developmental basis of the papilla agenesis at 17 dpc
is not clear. It is possible that alteration in the number or
position of early branch point in the ureteric duct is altered
or that cell movement processes such as convergent extension
are impaired.
We could not find reports of any equivalent human malfor-
mation, although congenital overgrowth of the renal papilla
has been rarely reported (21–24). We could find seven
mouse mutants with ‘abnormal kidney papilla morphology’
listed in MGI including inactivation of angiotensin or its
receptors (Agt, Agtr1a and Agtr1b), aquaporin (Aqp2),
Cdkn1c, Fgf7, Lepr and Adamts1. It will be interesting to
determine if any or all of these genes turn out to be transcrip-
tionally controlled by Esrrg. Most of these mutations were
associated with more extensive renal and extrarenal problems;
however, it is interesting that mutations in AQP2 cause
Figure 6. Quantitative analysis of Esrrg2/2 mouse embryonic kidneys using OPT imaging. Digital sections from OPT scans of paired 17 dpc embryonic kidneys
dissected from littermates of Esrrg+/2/Esrrg+/2 matings. Eight kidneys from four wild-type embryos (WT), six kidneys from three Esrrg+/2 embryos (HET) and
six kidneys from three Esrrg2/2 embryos (KO) are shown in midline saggital plane defined by analysis of the 3D digital image. The graph shows the range (box),
mean (solid line) and error bars (dotted lined) for each genotype group of the luminal volume (right-hand graph) and ratio of lumen to kidney parenchyma for
whole kidneys.
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nephrogenic diabetes insipidus and mutations in either AGT or
AGTR1A cause renal tubular dysgenesis in humans. These
phenotypes may provide informative cohorts in which to
look for mutations in ESRRG.
Finally, to return to our original hypothesis, it seems unli-
kely, given the mild and apparently asymptomatic phenotype
we have observed in the mouse, that inactivating mutations
of ESRRG are the sole cause of the bilateral renal agenesis
in the t(1;2)(q41;p25.3) case. It may be that mice are simply
much more tolerant of Esrrg dosage than humans. However,
it is plausible, given the effect of the Esrrg-agonist on the cul-
tured kidney, that aberrant activation of ESRRG occurs via
gain of a renal enhancer element or loss of a specific repressor
may be a causative cis-regulatory mutation in that case. Impor-
tant future work will include investigating CAKUT cases for
copy number variants that may result in duplication of
ESRRG transcription unit or of enhancers controlling the
renal expression of this gene.
MATERIALS AND METHODS
Immunohistochemical analysis
Four to 6 mm sections from paraformaldehyde-fixed,
paraffin-embedded wild-type CD1 mouse embryos were used
for immunohistochemical localization of Esrrg with a rabbit
polyclonal antiserum (AbCam, cat ab12988) at a dilution of 1
in 500. De-waxed sections were boiled in 10 mM citrate buffer
twice for 30 s and left to cool in the buffer for 20 min. Ten
percent heat-inactivated sheep serum in PBS was applied to
reduce non-specific binding. The slides were incubated in the
primary antibody at 48C overnight in a humidified chamber,
washed and the secondary antibody (biotinylated anti-rabbit
IgG, 1 in 1000) applied for 1 h at room temperature. Detection
was performed using the Vector Lab ABC kit and NBT/BCIP
and sectionswere counterstainedwith eosin. The antibody stain-
ing protocols used to assess proliferation (1/800 Phospho-
Histone H3, Cell Signaling, 9701) and apoptosis (1/200
Cleaved Caspase-3, Cell Signaling, 9661) were performed
using a minor modification of a previously reported method
(25). The modifications were that sections were microwaved
in TEG buffer (1.211 g Tris, 0.190 g EGTA in distilled water
to 1000 ml, pH 9.0) using a pressure cooker for 4 min and
detected using diaminobenzidine (Kem-En-Tec Diagnostics
A/S, Denmark) and the sections were counter stained with
Mayer’s haemalum (Fisher Scientific).
On cultured embryonic kidneys, the following primary anti-
bodies and dilutions were used: Laminin 1/200 (Sigma,
L9393), Calbindin 1/200 (Abcam, ab9481), Esrrg 1/200 (R&D
Systems, PP-H6812-00), WT1-F6 1/100 (Santa Cruz, sc7385)
and Pax8 1/200 (ProteinTech, 10336-1-AP). Cultured kidneys
were incubated in primary antibody overnight at 48C. The
Figure 7. Pathological features of Esrrg2/2 mouse embryonic kidneys. Photomicrographs of sections from wild-type (A, B, C) and Esrrg2/2 (D, E, F) littermate
17 dpc embryos. (A) The wild-type can be clearly divided into an outer cortex containing the vast majority of developing glomeruli and an inner medullary
region in which a blunt papilla is projecting into a mildly dilated pelvis. (B) The wild-type cortex shows a maturational gradient of nephrogenesis from sub-
capsular condensation of metanephric mesenchyme around ureteric buds, slightly deeper epithelialization, early morphogenesis (comma and s-shaped
bodies), nascent glomeruli at the outer third of the cortex and maturing glomeruli and maturation of convoluted tubules in the deeper cortex. (C) The wild-type
medulla, in addition to prominent radiating collecting ducts, contains scattered primitive loops of Henle. Interstitial mesenchymal cells are plump fusiform cells
beginning to form parallel arrays. (D) The Esrrg2/2 kidney has a marked distortion of the medullary architecture with nearly normal cortical architecture and
nephrogenesis. The medulla, instead of forming a normal blunt cone projecting into the pelvis, forms a concave disc beneath the cortex over a widely dilated
pelvis. The ureter, however, is not dilated. (E) The cortex shows the same maturational gradient as the wild-type from condensation through tubular maturation.
Glomerular maturation appears slightly retarded. (F). The medulla contains radiating collecting ducts, primitive loops of Henle and palisades of interstitial cells
but lacks a papilla.
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following day, six 1 h washes in PBST (PBS with 1% Triton
X-100) were carried out at room temperature. Secondary anti-
bodies: Alexa 594 donkey anti-rabbit IgG 1/400 (Invitrogen,
A21207) and Alexa 488 donkey anti-mouse 1/400 (Invitrogen,
A21202) were incubated overnight at 48C, followed by six 1 h
washes in PBST as above. The kidneys were mounted in Vecta-
shieldmountingmedium for fluorescence (Vector Labs,H-100).
Immunofluorescence was observed and recorded on an imaging
system comprising a Coolsnap HG CCD camera (Photometrics
Ltd, Tucson, AZ, USA) and Zeiss Axioplan II fluorescence
microscope with Plan-neofluar objectives. Image capture and
analysis were performed using in-house scripts written for
IPLab Spectrum (Scanalytics Corp., Fairfax, VA, USA).
In vitro mouse embryonic kidney culture
Kidneys at the T-bud stage of development were isolated from
11.5 dpc wild-type embryos (cd1 × cd1). These were cultured
on 0.4 mm pore size Transwell filters (Costar, 3450). The
kidneys were cultured at 378C with 5% CO2 in Minimum
Essential Medium Eagle medium (Sigma M5650) sup-
plemented with 10% newborn calf serum and 1% penicillin
and streptomycin. Kidneys were fixed in ice-cold methanol
for 10 min, washed briefly in PBS and blocked in PBS, BSA
and sodium azide overnight at 48C.
siRNA knock-down in cultured mouse embryonic kidneys
RNAi in kidney organ cultures were performed as previously
reported (26) with some modifications. Kidneys at the T-bud
stage of development were isolated from 11.5 dpc wild-type
embryos (cd1 × cd1) and cultured on 0.4 mm pore size Trans-
well filters (Costar, 3450). Two separate mixes were prepared,
the first one consisting of 30 ml of total siRNA (20 mM stock)
and 1150 ml of Improved MEM, Zinc Option (Gibco 10373)
supplemented with 10 mg/ml iron-loaded human transferrin
(Sigma) medium. siRNAs were available commercially from
Invitrogen (Esrrg siRNA, 10620312) and Ambion (Ush2a
control siRNA, AM16704). The second mix consisted of
69 ml of Lipofectamine-2000 (Invitrogen) in 350 ml of
Improved MEM, Zinc Option medium (Gibco 10373) sup-
plemented with 10 mg/ml of iron-loaded human transferrin.
These mixes were incubated for 10 min at room temperature
and subsequently the lipofectamine mix was added dropwise
to the siRNA mix. After a further 20 min incubation at room
temperature, 1.5 ml was placed in the bottom of the transwell,
and a 100 ml was pipetted gently on top of the kidneys. Fol-
lowing 24 h incubation, the medium was changed to
Minimum Essential Medium Eagle (Sigma M5650) with
10% newborn calf serum, and 1% penicillin and streptomycin,
and the kidneys cultured for a further 2 days. The kidneys
were cultured at 378C with 5% CO2.
Esrrg agonist application to cultured mouse embryonic
kidneys
Kidneys at the T-bud stage of development were isolated from
11.5 dpc wild-type embryos (CD1 × CD1), and cultured as
described above. Esrrg agonist, GW4716 (Sigma), was dis-
solved in ethanol and added to Minimum Essential Medium
Figure 8. Esrrg2/2 mouse embryonic kidneys appear normal at 14.5 dpc. Photomicrographs of sections from wild-type (A, B, C), heterozygous (D, E, F) and
Esrrg2/2 (G, H, I) littermate 14.5 dpc embryos. These sections have been stained with H&E (A, D, G), an antibody that detects phosphorylated histone H3 as a
marker of cells undergoing mitosis (pH 3; B, E, H) and an antibody that detects activated caspase 3 as a marker for apoptosis (Caspase; C, F, I). No obvious
differences could be detected between the genotypes in any of the staining groups. There were relatively few apoptotic cells in the kidney at this stage and those
that were present localized to the ducts (white arrowheads).
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Eagle medium (Sigma M5650) supplemented with 10%
newborn calf serum and 1% penicillin and streptomycin at
concentrations of 0–5 and 10 mM. The same total volume of
ethanol was used in each condition. Kidneys were cultured
at 378C with 5% CO2 for 3 days. The kidneys were then
fixed in ice-cold methanol for 10 min, washed briefly in PBS
and blocked in PBS, BSA-Azide overnight at 48C, before
staining with laminin and calbindin.
OPT and quantitative analysis
Mouse embryonic kidneys were fixed in 4% paraformaldehyde
overnight, mounted in 1% agarose, dehydrated in methanol
and then cleared overnight in BABB (1 part Benzyl Alcohol:
2 parts Benzyl Benzoate) (27). Each kidney was separately
imaged using a Bioptonics OPT Scanner 3001 (Bioptonics,
UK) with tissue autofluorescence (excitation 425 nm/emission
475 nm) used to capture the anatomy. The resulting images
were reconstructed using Bioptonics proprietary software.
The resulting 3D digital representations were imported into
Amira for digital sectioning and quantitative assessments.
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